Peter A S Johnstone1, David Boulware2, Rosa Djajadiningrat3, Sarah Ottenhof3, Andrea Necchi4, Mario Catanzaro4, Dingwei Ye5, Yao Zhu5, Nicola Nicolai4, Simon Horenblas3, Philippe E Spiess6. 1. Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: Peter.Johnstone@Moffitt.org. 2. Department of Bioinformatics and Biostatistics, Moffitt Cancer Center, Tampa FL, USA. 3. Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. 4. Department of Urology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy. 5. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. 6. Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Abstract
BACKGROUND: In head and neck cancer, the presence of extranodal extension (ENE) in lymph nodes (LNs) has been shown prospectively to require adding chemotherapy to postoperative radiation therapy (RT). Limited data exist regarding ENE in LNs from primary penile cancer (PeCa). OBJECTIVE: To determine the association of RT and ENE in PeCa. DESIGN, SETTING, AND PARTICIPANTS: We retrospectively analyzed the outcomes of 93 patients with pT1-4 N3 M0 (American Joint Committee on Cancer 7th edition) squamous cell carcinoma of the penis across four international centers. INTERVENTION: If the inguinal nodal specimen had ENE or two or more positive inguinal LNs, RT was delivered to an ipsilateral inguinal field. An ipsilateral pelvic field was added for positive pelvic LNs on dissection. The delivered dose was usually 50Gy in 25 daily fractions. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Clinical and demographic characteristics of relapse-free (RFS), disease-specific (DSS), and overall (OS) survival were compared by ENE status and receipt of adjuvant RT. RESULTS AND LIMITATIONS: Seventy-two percent of patients had inguinal ENE, and 49% had pelvic ENE. On multivariable analysis (MVA) of ENE-negative patients, an OS benefit was noted with postoperative chemotherapy (p=0.038) and inguinopelvic RT (p=0.037). RFS suffered with worsening grade of the lesion (moderately: p=0.027; poorly: p=0.038), but was improved with groin (p=0.016) and inguinopelvic (p=0.006) RT. On MVA of patients with ENE, inguinopelvic RT was associated with better DSS (p=0.041). Grade impacted DSS (moderately: p=0.043; poorly: p=0.033), and poorly differentiated lesions impacted RFS (p=0.013). CONCLUSIONS: Inguinopelvic RT may benefit regional control in PeCa patients with positive pelvic LNs, but this appears to be limited to those without ENE. PATIENT SUMMARY: For patients with penile cancer and positive pelvic lymph nodes, postoperative radiation therapy was found to decrease the likelihood of disease recurrence in the groin or pelvis only if extranodal extension was absent.
BACKGROUND: In head and neck cancer, the presence of extranodal extension (ENE) in lymph nodes (LNs) has been shown prospectively to require adding chemotherapy to postoperative radiation therapy (RT). Limited data exist regarding ENE in LNs from primary penile cancer (PeCa). OBJECTIVE: To determine the association of RT and ENE in PeCa. DESIGN, SETTING, AND PARTICIPANTS: We retrospectively analyzed the outcomes of 93 patients with pT1-4 N3 M0 (American Joint Committee on Cancer 7th edition) squamous cell carcinoma of the penis across four international centers. INTERVENTION: If the inguinal nodal specimen had ENE or two or more positive inguinal LNs, RT was delivered to an ipsilateral inguinal field. An ipsilateral pelvic field was added for positive pelvic LNs on dissection. The delivered dose was usually 50Gy in 25 daily fractions. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Clinical and demographic characteristics of relapse-free (RFS), disease-specific (DSS), and overall (OS) survival were compared by ENE status and receipt of adjuvant RT. RESULTS AND LIMITATIONS: Seventy-two percent of patients had inguinal ENE, and 49% had pelvic ENE. On multivariable analysis (MVA) of ENE-negative patients, an OS benefit was noted with postoperative chemotherapy (p=0.038) and inguinopelvic RT (p=0.037). RFS suffered with worsening grade of the lesion (moderately: p=0.027; poorly: p=0.038), but was improved with groin (p=0.016) and inguinopelvic (p=0.006) RT. On MVA of patients with ENE, inguinopelvic RT was associated with better DSS (p=0.041). Grade impacted DSS (moderately: p=0.043; poorly: p=0.033), and poorly differentiated lesions impacted RFS (p=0.013). CONCLUSIONS: Inguinopelvic RT may benefit regional control in PeCa patients with positive pelvic LNs, but this appears to be limited to those without ENE. PATIENT SUMMARY: For patients with penile cancer and positive pelvic lymph nodes, postoperative radiation therapy was found to decrease the likelihood of disease recurrence in the groin or pelvis only if extranodal extension was absent.
Authors: Jay S Cooper; Thomas F Pajak; Arlene A Forastiere; John Jacobs; Bruce H Campbell; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Mitchell Machtay; John F Ensley; K S Clifford Chao; Christopher J Schultz; Nancy Lee; Karen K Fu Journal: N Engl J Med Date: 2004-05-06 Impact factor: 91.245
Authors: Richard Robinson; Lorenzo Marconi; Ekelechi MacPepple; Oliver W Hakenberg; Nick Watkin; Yuhong Yuan; Thomas Lam; Steven MacLennan; Temitope E Adewuyi; Alberto Coscione; Suks S Minhas; Eva M Compérat; Andrea Necchi Journal: Eur Urol Date: 2018-04-24 Impact factor: 20.096
Authors: Dominic H Tang; Rosa Djajadiningrat; Gregory Diorio; Juan Chipollini; Zhenjun Ma; Braydon J Schaible; Mario Catanzaro; Dingwei Ye; Yao Zhu; Nicola Nicolai; Simon Horenblas; Peter A S Johnstone; Philippe E Spiess Journal: Urol Oncol Date: 2017-06-27 Impact factor: 3.498
Authors: Pranav Sharma; Rosa Djajadiningrat; Kamran Zargar-Shoshtari; Mario Catanzaro; Yao Zhu; Nicola Nicolai; Simon Horenblas; Philippe E Spiess Journal: Urol Oncol Date: 2015-06-10 Impact factor: 3.498
Authors: Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre Journal: Head Neck Date: 2005-10 Impact factor: 3.147
Authors: Anne P Lont; Bin K Kroon; Maarten P W Gallee; Harm van Tinteren; Luc M F Moonen; Simon Horenblas Journal: J Urol Date: 2007-03 Impact factor: 7.450
Authors: Klaus L Prenzel; Arnulf H Hölscher; Uta Drebber; Elfriede Bollschweiler; Christian A Gutschow; Dirk L Stippel; Stefan P Mönig Journal: Pancreas Date: 2014-01 Impact factor: 3.327
Authors: L J Peters; H Goepfert; K K Ang; R M Byers; M H Maor; O Guillamondegui; W H Morrison; R S Weber; A S Garden; R A Frankenthaler Journal: Int J Radiat Oncol Biol Phys Date: 1993-04-30 Impact factor: 7.038
Authors: Hakan Alakus; Arnulf H Hölscher; Guido Grass; Eva Hartmann; Christian Schulte; Uta Drebber; Stephan E Baldus; Elfriede Bollschweiler; Ralf Metzger; Stefan P Mönig Journal: Cancer Date: 2010-01-15 Impact factor: 6.860
Authors: Peter A S Johnstone; Hielke M de Vries; Juan Chipollini; G Daniel Grass; Franklin Boyd; Fernando Korkes; Maarten Albersen; Eduard Roussel; Yao Zhu; Ding-Wei Ye; Viraj Master; Thien-Linh Le; Asif Muneer; Oscar R Brouwer; Philippe E Spiess Journal: Clin Transl Radiat Oncol Date: 2021-08-09